Lee Ho-Su, Choe Jaewon, Kim Seon-Ok, Lee Sun-Ho, Lee Hyo Jeong, Seo Hyungil, Kim Gwang-Un, Seo Myeongsook, Song Eun Mi, Hwang Sung Wook, Park Sang Hyoung, Yang Dong-Hoon, Kim Kyung-Jo, Ye Byong Duk, Byeon Jeong-Sik, Myung Seung-Jae, Yoon Yong Sik, Yu Chang Sik, Kim Jin-Ho, Yang Suk-Kyun
Department of Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Biostatistics and Clinical Epidemiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Gastroenterol Hepatol. 2017 Apr;32(4):782-788. doi: 10.1111/jgh.13596.
Limited data are available regarding mortality from inflammatory bowel disease in non-Caucasian populations. Herein, we evaluated overall and cause-specific mortality in a hospital-based cohort of Korean inflammatory bowel disease patients.
We determined mortality in 2414 Crohn's disease patients and 2798 ulcerative colitis patients diagnosed between 1977 and 2013. Standardized mortality ratios were calculated in several demographic and phenotypic subgroups.
During the mean 9-year follow up, 114 patients died: 35 with Crohn's disease and 79 with ulcerative colitis. The overall standardized mortality ratios were 1.40 (95% confidence interval: 0.97-1.94) in Crohn's disease and 0.73 (0.58-0.91) in ulcerative colitis. In Crohn's disease, female sex, age < 30 years at diagnosis, disease duration > 10 years, ileocolonic disease at diagnosis, perianal fistula, intestinal resection, and ever-use of corticosteroids were associated with higher mortality. In ulcerative colitis, male sex, age ≥ 30 years at diagnosis, disease duration ≤ 5 years, proctitis at diagnosis, and no history of colectomy were associated with lower mortality, while primary sclerosing cholangitis was associated with higher mortality. In both Crohn's disease and ulcerative colitis, high mortality rates due to nonmalignant gastrointestinal causes (standardized mortality ratios: 4.59 and 2.32, respectively) and gastrointestinal malignancies (standardized mortality ratios: 16.59 and 3.45, respectively) were observed. Cardiovascular mortality was lower in ulcerative colitis (standardized mortality ratio: 0.47).
The overall mortality tended to be higher in Crohn's disease patients than in the general population; it was slightly lower in ulcerative colitis patients than in the general population.
关于非白种人群炎性肠病死亡率的数据有限。在此,我们评估了以医院为基础的韩国炎性肠病患者队列中的全因死亡率和病因特异性死亡率。
我们确定了1977年至2013年间诊断的2414例克罗恩病患者和2798例溃疡性结肠炎患者的死亡率。计算了几个人口统计学和表型亚组的标准化死亡率。
在平均9年的随访期间,114例患者死亡:35例克罗恩病患者和79例溃疡性结肠炎患者。克罗恩病的总体标准化死亡率为1.40(95%置信区间:0.97 - 1.94),溃疡性结肠炎为0.73(0.58 - 0.91)。在克罗恩病中,女性、诊断时年龄<30岁、病程超过10年、诊断时为回结肠疾病、肛周瘘管、肠道切除术以及曾使用皮质类固醇与较高死亡率相关。在溃疡性结肠炎中,男性、诊断时年龄≥30岁、病程≤5年、诊断时为直肠炎且无结肠切除术史与较低死亡率相关,而原发性硬化性胆管炎与较高死亡率相关。在克罗恩病和溃疡性结肠炎中,均观察到非恶性胃肠道病因导致的高死亡率(标准化死亡率分别为4.59和2.32)以及胃肠道恶性肿瘤导致的高死亡率(标准化死亡率分别为16.59和3.45)。溃疡性结肠炎的心血管死亡率较低(标准化死亡率:0.47)。
克罗恩病患者的总体死亡率往往高于一般人群;溃疡性结肠炎患者的总体死亡率略低于一般人群。